182 related articles for article (PubMed ID: 36474298)
1. Discovery of a pyrano[2,3-b]pyridine derivative YX-2102 as a cannabinoid receptor 2 agonist for alleviating lung fibrosis.
Liu T; Gu J; Yuan Y; Yang Q; Zheng PF; Shan C; Wang F; Li H; Xie XQ; Chen XH; Ouyang Q
J Transl Med; 2022 Dec; 20(1):565. PubMed ID: 36474298
[TBL] [Abstract][Full Text] [Related]
2. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition.
Wu YX; Zhang YR; Jiang FJ; He S; Zhang YL; Chen D; Tong Y; Nie YJ; Pang QF
Inflamm Res; 2023 Jun; 72(6):1133-1145. PubMed ID: 37169970
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and down-regulating TLR4/NF-κB and TGF-β1/smad3 signalling pathways in rats.
Wang L; Shao M; Jiang W; Huang Y
Tissue Cell; 2022 Dec; 79():101953. PubMed ID: 36228366
[TBL] [Abstract][Full Text] [Related]
5. Timosaponin BII inhibits TGF-β mediated epithelial-mesenchymal transition through Smad-dependent pathway during pulmonary fibrosis.
Ding D; Shen X; Yu L; Zheng Y; Liu Y; Wang W; Liu L; Zhao Z; Nian S; Liu L
Phytother Res; 2023 Jul; 37(7):2787-2799. PubMed ID: 36807664
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
[TBL] [Abstract][Full Text] [Related]
7. A selective CB2R agonist (JWH133) protects against pulmonary fibrosis through inhibiting FAK/ERK/S100A4 signaling pathways.
Wu X; Chen L; Cheng Y; Zhang Y; Yang W; Pan L; Fu C; Zhu H; Zhang M
BMC Pulm Med; 2023 Nov; 23(1):440. PubMed ID: 37957604
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Notch-1/Twist-1 axis in the process of epithelial-mesenchymal transition of type II alveolar epithelial cell and its mechanism].
Tang J; Ke J; Fu Y; He XW; Li XW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):577-583. PubMed ID: 34821087
[No Abstract] [Full Text] [Related]
9. Salvia miltiorrhiza Bunge extract and Przewalskin ameliorate Bleomycin-induced pulmonary fibrosis by inhibition of apoptosis, oxidative stress and collagen deposition via the TGF-β1 pathway.
Zeng M; Feng A; Ren Y; Zhang Q; Wang R; Zhang B; Liu M; Guo P; Zhang Y; Lyu J; Zheng X
Phytomedicine; 2024 Mar; 125():155339. PubMed ID: 38237513
[TBL] [Abstract][Full Text] [Related]
10. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
11. Calycosin attenuates pulmonary fibrosis by the epithelial-mesenchymal transition repression upon inhibiting the AKT/GSK3β/β-catenin signaling pathway.
Liu X; Shao Y; Zhang X; Ji X; Xie M; Liu H
Acta Histochem; 2021 Jul; 123(5):151746. PubMed ID: 34217047
[TBL] [Abstract][Full Text] [Related]
12. CB2R agonist prevents nicotine induced lung fibrosis.
Wawryk-Gawda E; Chłapek K; Zarobkiewicz MK; Lis-Sochocka M; Chylińska-Wrzos P; Boguszewska-Czubara A; Sławiński MA; Franczak A; Jodłowska-Jędrych B; Biała G
Exp Lung Res; 2018 Sep; 44(7):344-351. PubMed ID: 30675824
[TBL] [Abstract][Full Text] [Related]
13. Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2.
Luo XQ; Li A; Yang X; Xiao X; Hu R; Wang TW; Dou XY; Yang DJ; Dong Z
Chin Med; 2018; 13():14. PubMed ID: 29560022
[TBL] [Abstract][Full Text] [Related]
14. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.
Zhang Z; Qu J; Zheng C; Zhang P; Zhou W; Cui W; Mo X; Li L; Xu L; Gao J
Cell Death Dis; 2018 Jan; 9(2):83. PubMed ID: 29362432
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of partial activation of cannabinoid receptor type 2 and identification of potential partial agonists: Molecular dynamics simulation and structure-based virtual screening.
Uba AI; Aluwala H; Liu H; Wu C
Comput Biol Chem; 2022 Aug; 99():107723. PubMed ID: 35850049
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
18. Chlorogenic Acid Inhibited Epithelial-Mesenchymal Transition to Treat Pulmonary Fibrosis through Modulating Autophagy.
Mao X; Xie X; Ma J; Wei Y; Huang Z; Wang T; Zhu J; Wang Y; Zhao H; Hua J
Biol Pharm Bull; 2023; 46(7):929-938. PubMed ID: 37394644
[TBL] [Abstract][Full Text] [Related]
19. Total extract of Xin Jia Xuan Bai Cheng Qi decoction inhibits pulmonary fibrosis via the TGF-β/Smad signaling pathways in vivo and in vitro.
Qin H; Wen HT; Gu KJ; Hu XD; Yang T; Yan XF; Ye TJ; Huo JL; Hu J
Drug Des Devel Ther; 2019; 13():2873-2886. PubMed ID: 31695321
[TBL] [Abstract][Full Text] [Related]
20. Activation of type 2 cannabinoid receptor (CB2R) by selective agonists regulates the deposition and remodelling of the extracellular matrix.
Guan T; Zhao G; Duan H; Liu Y; Zhao F
Biomed Pharmacother; 2017 Nov; 95():1704-1709. PubMed ID: 28958132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
